Avenue therapeutics reports q2 loss per share $0.11

Avenue therapeutics reports second quarter 2020 financial results and recent corporate highlights.q2 loss per share $0.11.q2 earnings per share view $-0.11 -- refinitiv ibes data.
ATXI Ratings Summary
ATXI Quant Ranking